Clinical Trial Update: Growth Hormone in Children With Juvenile Rheumatoid Arthritis (JRA) and With Crohn's Disease [Phase 2, Phase 3]

View source ↗

Summary

The Phase 2/3 trial evaluating growth hormone in children with Juvenile idiopathic arthritis and Crohn's disease was terminated, and results were posted in 2018…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Juvenile Idiopathic Arthritis

Drugs mentioned

• Growth Hormone (somatropin)

Snippet

Sponsor: Nationwide Children's Hospital | Conditions: Arthritis, Juvenile Rheumatoid, Crohn Disease | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2018-04-12